Cancer Immunology

CME

In recent years, there has been a revolution in cancer biology that has changed how we treat patients. For any doctor or scientist who finished school prior to 2005, much of this information is new. This course was designed in response to feedback from both junior and senior faculty seeking a better understanding of basic concepts of cancer genomics, epigenomics, and targeted therapeutics.

Educational Objectives

As a result of this activity, participants will be expected to improve their practice by:

1. Having a better understanding of the components of the immune system and how they may be used to treat cancer
2. Appreciating what cancer immunotherapeutic techniques may be applicable to their patients with specific cancers
3. Gaining awareness of potential side effects of cancer immunotherapy
4. Learning about ongoing cancer immunotherapy research at MSK, which may help them identify trials for which their patients are eligible, colleagues who can consult on their patients, and potential collaborators in translational research

Event Information

Date & Time(s)
Tuesday, September 9, 2014, 12:00 PM – 1:00 PM
Sponsor(s)

Memorial Sloan Kettering Cancer Center

Speaker(s)

Course Director: Laura Liberman, MD

Audience

Researchers, nurses, trainees, staff; anyone involved in cancer care or research would benefit from a better understanding of cancer immunotherapy.

Agenda

Cancer Immunotherapy at MSK: Where we are and how we got there (everything else is someone else’s talk)
Date: September 9, 2014
Time: 12-1 pm
Speaker: Jedd Wolchok, MD, PhD

Cancer Immunotherapy 101
Date: September 16, 2014
Time: 12-1 pm
Speaker: Dmitriy Zamarin, MD

Cancer Immunotherapy: The Tumor Microenvironment
Date: September 23, 2014
Time: 12-1 pm
Speaker: Johanna Joyce, PhD

Cancer Immunotherapy: Allogeneic hematopoietic stem cell therapy, the original immunotherapy of cancer
Date: September 29, 2014 (Note: this is a Monday!)
Time: 12-1 pm
Speaker: Marcel van den Brink, MD, PhD

Cancer Immunotherapy: Chimeric Antigen Receptor (CAR) T Cell Therapy for Leukemia
Date: October7, 2014
Time: 12-1 pm
Speaker: Renier Brentjens, MD, PhD

Cancer Immunotherapy: Principles of Chimeric Antigen Receptor (CAR) T Cell Therapy
Date: October14, 2014
Time: 12-1 pm
Speaker: Michel Sadelain, MD, PhD

Cancer Immunotherapy: Targeting Undruggable Cancer Targets with Antibodies
Date: October 21, 2014
Time: 12-1 pm
Speaker: David A. Scheinberg, MD, PhD

Credit

Memorial Sloan-Kettering Cancer Center designates this conference for a maximum of 1.0 AMA PRA Category 1 Credits™. Each physician should claim only those hours of credit he/she actually spent in the conference.

Location Information

Zuckerman Research Center
Auditorium
417 East 68th Street
between York and 1st Avenues
New York, NY 10065

Contact Information

Contact

RSVP to ofd@mskcc.org if you’d like to attend.